[Statistics on oncological urologic diseases in Russia]

Area of Science:

• Urology
• Oncology
• Public Health

Background:

• Male urogenital cancer incidence rates have significantly increased.
• Trends in prevalence, morbidity, and mortality require detailed examination.

Purpose of the Study:

• To outline disease-specific trends in male urogenital cancer.
• To analyze the contributing factors to the rising incidence.
• To assess the impact on lifespan and economic losses.

Main Methods:

• Analysis of incidence, prevalence, morbidity, and mortality data for male urogenital cancer.
• Statistical evaluation of trends from 1975 to 1993.
• Calculation of lifespan reduction and economic losses.

Main Results:

• Urogenital cancer incidence rose by 138.7% from 1975-1993, reaching 27,700 cases.
• Increased risk of developing the disease is the primary driver, not population aging.
• Mortality from urogenital cancer reduces mean lifespan by 2 months and fatal cases by 11-19 years.
• Economic losses due to urogenital cancer deaths were estimated at 187.3 million rubles (1990 prices).

Conclusions:

• The rising incidence of male urogenital cancer is a significant public health concern.
• The disease has a profound impact on life expectancy and incurs substantial economic costs.
• Further research and preventative strategies are warranted to address this trend.